Compare TELA & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TELA | ARAY |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3M | 39.3M |
| IPO Year | 2019 | 2006 |
| Metric | TELA | ARAY |
|---|---|---|
| Price | $0.70 | $0.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.00 | ★ $3.50 |
| AVG Volume (30 Days) | 37.7K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.59 | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $80,275,000.00 | N/A |
| Revenue This Year | $10.23 | N/A |
| Revenue Next Year | $14.26 | $4.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $0.22 |
| 52 Week High | $2.14 | $2.10 |
| Indicator | TELA | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 49.21 |
| Support Level | $0.67 | $0.24 |
| Resistance Level | $0.95 | $0.29 |
| Average True Range (ATR) | 0.07 | 0.02 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 25.36 | 55.87 |
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.